Trial intelligence / Profile preview

Phase II double-blind randomized placebo-controlled trial of SA09012 in bronchial asthma

KCT0000571Phase 2Completed

Sponsor
Sam-A Pharm
Start
Nov 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of masilukast in asthma, sponsored by Sam-A Pharm. Started Nov 2012; status: completed.

02

Drugs

masilukast
03

Conditions

asthma

Beyond the preview

Go deeper on KCT0000571.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0000571.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call